TIMP1 and breast cancer: Mechanistically, TINs induce migration, invasion, and epithelial-to-mesenchymal transition (EMT) of breast cancer cells through production of tissue inhibitor of metalloproteinase 1 (TIMP1) and subsequent induction of CD90 [19].